SFI
TLSA icon

Susquehanna Fundamental Investments’s Tiziana Life Sciences TLSA Stock Holding History

Susquehanna Fundamental Investments’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-44,566
Closed -$90K – 1616
2020
Q4 		$90K Sell
44,566
-6,200
-12% -$19.6K ﹤0.01% 1430
2020
Q3 		$170K Buy
+50,766
New +$198K 0.01% 1222

Other funds holding TLSA

HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
AFP
Ausdal Financial Partners Davenport, Iowa $2.25B AUM 20.11% 1-Year Est. Return
CAAS
Capital Asset Advisory Services Williamston, Michigan $2.61B AUM 15.59% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna Fundamental Investments's TLSA Position: Q1 2021 in Review

Susquehanna Fundamental Investments sold out of Tiziana Life Sciences (TLSA) in Q1 2021, closing a stake of 44,566 shares — an estimated $90K sold.

Susquehanna Fundamental Investments first reported a position in TLSA in Q3 2020 and held it in 2 quarters. The position peaked at $170K in Q3 2020. 23 funds tracked by Wall St. Rank hold TLSA as of Q1 2021.

  • Susquehanna Fundamental Investments reported no remaining Tiziana Life Sciences position as of Q1 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 44,566 Tiziana Life Sciences shares in Q1 2021, an estimated $90K.
  • Susquehanna Fundamental Investments first reported a position in Tiziana Life Sciences in Q3 2020 and held it in 2 quarters.
  • Susquehanna Fundamental Investments's Tiziana Life Sciences position peaked at $170K in Q3 2020.
  • 23 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2021, filed 17 May 2021.